Feed Preview

Fast Growing

Anti-Arrhythmic Drug Therapies

Anti-Arrhythmic Drug Therapies diagram by BARRUS, Shutterstock
BARRUS, Shutterstock

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Top 20 most recent papers
May 18, 2020

Gene-editing pipeline takes off

Nature Reviews. Drug Discovery
Asher Mullard
May 10, 2020

Shortening jet-lag recovery

Nature Reviews. Drug Discovery
Sarah Crunkhorn
May 14, 2020

Protective effects of Ranolazine on testicular torsion and detorsion injury in rats

Bilge Bugra KeserogluKoray Agras
May 22, 2020

Dofetilide Initiation and Implications of Deviation From the Standard Protocol - A Real World Experience

Journal of Atrial Fibrillation
Tawseef DarDhanunjaya Lakkireddy
May 12, 2020
Open Access

Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms

Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
Frank LindemannCosima Jahnke
May 13, 2020

Parkinson disease setback

Nature Reviews. Drug Discovery
Asher Mullard
May 15, 2020

KNa 1.1 channels as a target for treating early-onset epilepsy

Nature Reviews. Drug Discovery
Zicheng HuOlga Gulyaeva
May 13, 2020

Rationale and study design for ablation of paroxysmal atrial fibrillation guided by ablation index: a multi-center, prospective randomized trial (PAF-AI trial)

Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
Ruhong JiangChenyang Jiang
May 19, 2020

Investigation of the Effect of HATCH Score and Coronary Artery Disease Complexity on Atrial Fibrillation After On-Pump Coronary Artery Bypass Graft Surgery

Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
Mesut Engin, Cihan Aydın
May 22, 2020
Open Access

Inhibition of KCa 2 and Kv 11.1 Channels in Pigs With Left Ventricular Dysfunction

Frontiers in Pharmacology
Carlotta CiterniJonas Goldin Diness
May 21, 2020
ReviewOpen Access

COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2

Frontiers in Cardiovascular Medicine
Alexander CarpenterAndrew F James
May 16, 2020
ReviewOpen Access

DNA Damage, an Innocent Bystander in Atrial Fibrillation and Other Cardiovascular Diseases?

Frontiers in Cardiovascular Medicine
Kennedy S Ramos, Bianca J J M Brundel
May 10, 2020

Targeting CDK12 to treat DM1

Nature Reviews. Drug Discovery
Sarah Crunkhorn
May 16, 2020

Remote digital monitoring in clinical trials in the time of COVID-19

Nature Reviews. Drug Discovery
Jennifer C GoldsackJohn A Wagner

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2020 Meta ULC. All rights reserved